T -- Supplemental Publication to the Journal of Infectious Diseases
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Centers for Disease Control and Prevention plans to award a sole source purchase order to The University of Chicago Press to publish a special supplement to The Journal of Infectious Diseases (JID), the official publication of the Infectious Disease Society of America. This supplement, entitled "Updates in Varicella Zoster Vaccine," aims to be the authoritative source on this topic, reflecting the latest research and policy developments related to the varicella zoster vaccine. The contract's period of performance will extend for one year from the award date. As no solicitation document will be issued and telephone inquiries are not accepted, all questions must be submitted via email before the closing date. Interested parties are responsible for monitoring the FedbizOpps website for any additional postings or updates. The contract falls under NAICS code 511120, associated with publishing activities, and Berta L. Biltz serves as the contract specialist overseeing this procurement. This award supports critical dissemination of scientific knowledge relevant to infectious disease prevention and control.
General Info
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
